Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 14.61B |
| Enterprise Value | 31.54B |
| Trailing P/E | 872.00 |
| Forward P/E | 5.92 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.00 |
| Price/Book (mrq) | 2.13 |
| Enterprise Value/Revenue | 1.99 |
| Enterprise Value/EBITDA | 20.24 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.06 |
| 52-Week Change 3 | 60.23% |
| S&P500 52-Week Change 3 | 24.19% |
| 52 Week High 3 | 14.47 |
| 52 Week Low 3 | 7.09 |
| 50-Day Moving Average 3 | 13.51 |
| 200-Day Moving Average 3 | 10.83 |
Share Statistics
| Avg Vol (3 month) 3 | 9.77M |
| Avg Vol (10 day) 3 | 8.74M |
| Shares Outstanding 5 | 1.13B |
| Implied Shares Outstanding 6 | 1.13B |
| Float 8 | 1.11B |
| % Held by Insiders 1 | 0.00% |
| % Held by Institutions 1 | 52.77% |
| Shares Short (Apr 15, 2024) 4 | 11.56M |
| Short Ratio (Apr 15, 2024) 4 | 1.41 |
| Short % of Float (Apr 15, 2024) 4 | N/A |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 1.03% |
| Shares Short (prior month Mar 15, 2024) 4 | 10.46M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | 2.95 |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Dec 12, 2017 |
| Ex-Dividend Date 4 | Nov 27, 2017 |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Jul 01, 2004 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -3.53% |
| Operating Margin (ttm) | 28.05% |
Management Effectiveness
| Return on Assets (ttm) | 4.54% |
| Return on Equity (ttm) | -7.36% |
Income Statement
| Revenue (ttm) | 15.85B |
| Revenue Per Share (ttm) | 14.16 |
| Quarterly Revenue Growth (yoy) | 14.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | 4.33B |
| Net Income Avi to Common (ttm) | -559M |
| Diluted EPS (ttm) | -0.50 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.23B |
| Total Cash Per Share (mrq) | 2.88 |
| Total Debt (mrq) | 20.27B |
| Total Debt/Equity (mrq) | 249.48% |
| Current Ratio (mrq) | 1.02 |
| Book Value Per Share (mrq) | 6.70 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.37B |
| Levered Free Cash Flow (ttm) | 3.29B |
© 2024 Yahoo. All rights reserved.